Qualaquin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Frontida Biopharm, Inc.. The primary component is Quinine Sulfate.
| Product ID | 71557-047_5fdcdaf4-0760-4db6-b4b5-549e2154479f |
| NDC | 71557-047 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Qualaquin |
| Generic Name | Quinine Sulfate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-06-01 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA021799 |
| Labeler Name | Frontida BioPharm, Inc. |
| Substance Name | QUININE SULFATE |
| Active Ingredient Strength | 324 mg/1 |
| Pharm Classes | Antimalarial [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2017-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 13310-153 | Qualaquin | Quinine Sulfate |
| 49708-153 | Qualaquin | Quinine Sulfate |
| 71557-047 | Qualaquin | Quinine Sulfate |
| 0220-1306 | Chininum sulphuricum | QUININE SULFATE |
| 0220-1307 | Chininum sulphuricum | QUININE SULFATE |
| 0220-1310 | Chininum sulphuricum | QUININE SULFATE |
| 0220-1311 | Chininum sulphuricum | QUININE SULFATE |
| 0220-1314 | Chininum sulphuricum | QUININE SULFATE |
| 0220-1325 | Chininum sulphuricum | QUININE SULFATE |
| 62106-5706 | CHININUM SULPHURICUM | Quinine sulfate |
| 68428-310 | Chininum sulphuricum | QUININE SULFATE |
| 71919-189 | Chininum sulphuricum | QUININE SULFATE |
| 0093-3002 | Quinine Sulfate | Quinine Sulfate |
| 50742-238 | QUININE SULFATE | QUININE SULFATE |
| 53489-700 | Quinine Sulfate | Quinine Sulfate |
| 68084-947 | Quinine Sulfate | Quinine Sulfate |
| 68180-560 | QUININE SULFATE | QUININE SULFATE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() QUALAQUIN 78835655 3263197 Live/Registered |
MUTUAL PHARMACEUTICAL COMPANY, INC. 2006-03-13 |